Related Experiment Video
Updated: Jun 3, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Obesity and left ventricular dilatation in young adulthood: the Bogalusa Heart Study
Lydia A Bazzano1, Suresh N Belame, Dharmendrakumar A Patel
1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana 70112-2715, USA. lbazzano@tulane.edu
Insights
Obesity is a key predictor of left ventricular (LV) dilatation in young adults. This finding highlights the importance of weight management for cardiovascular health in both men and women.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Cardiac enlargement predicts adverse cardiovascular events.
- Left ventricular (LV) dilatation precedes LV dysfunction and heart failure.
- Study investigates risk factors for LV dilatation in young adults.
Purpose of the Study:
- Identify unique risk factors for LV dilatation in young adults.
- Examine predictors of LV dilatation across different sexes.
Main Methods:
- M-mode echocardiography used to determine ventricular dimensions indexed to height.
- LV dilatation defined as top 20th percentile of indexed LV end-diastolic dimension.
- Logistic regression models stratified by race and sex analyzed CV risk factors.
Main Results:
- Body mass index (BMI) significantly predicted LV dilatation in both men and women.
- Higher BMI was associated with increased odds of LV dilatation.
- Triglyceride levels predicted LV dilatation in men but not in women.
Conclusions:
- Obesity (indicated by BMI) is the most consistent predictor of LV dilatation in young adults.
- Triglyceride levels are a significant predictor of LV dilatation in men only.
- Findings emphasize the role of obesity in early cardiac changes.
Background:
Cardiac enlargement is an important predictor of adverse cardiovascular (CV) events. Left ventricular (LV) dilatation is a precursor both of LV dysfunction and clinical heart failure. The present study examines risk factors for LV dilatation among 832 young adults (341 male, 491 female) who participated in the Bogalusa Heart Study.
Hypothesis:
A unique set of risk factors predicts LV dilatation among young adults.
Methods:
Standard ventricular dimensions were determined by M-mode echocardiography and indexed to height using a standard method. LV dilatation was considered as the top 20th percentile of LV end-diastolic dimension indexed to height. Logistic regression models were used, stratified by race and sex, to assess the relationship of CV risk factors with quintile of LV end-diastolic dimension indexed to height.
Results:
The mean age (standard deviation) of men and women in the population was 36.4 years (3.9 years) and 35.9 years (4.6 years), respectively. In sex-specific models adjusted for age, race, systolic and diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and glycosylated hemoglobin, body mass index (BMI) was a significant predictor of LV dilatation in both men and women. The odds ratio (95% confidence interval) for a 1-unit change in BMI was 1.12 (1.02-1.19) in men and 1.09 (1.05-1.13) in women. Among men, triglyceride level was also significantly associated with LV dilatation (P=0.03), whereas among women there was no such association.
Conclusions:
Our findings indicate that obesity is the most consistent predictor of LV dilatation in both men and women, whereas triglyceride level was a significant predictor among men only.
More Related Videos
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Hypertension II: Pathophysiology
Obesity
Cardiomyopathy II: Dilated Cardiomyopathy